Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity
Umaña, Pablo, Jean–Mairet, Joël, Moudry, Radmila, Amstutz, Hanspeter, Bailey, James E.·1999·Nature Biotechnology
DOI 10.1038/6179
Cited by (764)
Items 301–400 of 764
- FX knockout CHO hosts can express desired ratios of fucosylated or afucosylated antibodies with high titers and comparable product qualitySalina Louie, Benjamin Haley, Brett Marshall, Amy J. Heidersbach, Mandy Yim, Martina Brozynski, Danming Tang, Cynthia Lam, Bronislawa Petryniak, David Shaw et al. · 2016 · Biotechnology and Bioengineering
- Antibody-Based Cancer TherapyDjoke Hendriks, Goda Choi, Marco de Bruyn, Valerie R. Wiersma, Edwin Bremer · 2017 · International review of cytology
- Strategies to Augment Natural Killer (NK) Cell Activity against Solid TumorsZiqing Chen, Ying Yang, Lisa L. Liu, Andreas Lundqvist · 2019 · Cancers
- Molecular analysis of three gain-of-function CHO mutants that add the bisecting GlcNAc to N-glycansPamela Stanley · 2004 · Glycobiology
- The role of N-glycosylation in B-cell biology and IgG activity. The aspects of autoimmunity and anti-inflammatory therapySara Trzos, Paweł Link‐Lenczowski, Ewa Pocheć · 2023 · Frontiers in Immunology
- A human anti‐D monoclonal antibody selected for enhanced FcγRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti‐D antibodiesRoland Béliard, Tony Waegemans, Dominique Notelet, Léna Massad, F. Dhainaut, Christophe de Romeuf, Eric Guémas, Wouter Haazen, Dominique Bourel, Jean‐Luc Teillaud et al. · 2008 · British Journal of Haematology
- Controlled release of therapeutic antibody formatsDaniel Schweizer, Tim Serno, Achim M. Göpferich · 2014 · European Journal of Pharmaceutics and Biopharmaceutics
- Human cell lines for the production of recombinant proteins: on the horizonLukas Fliedl, Johannes Grillari, Regina Grillari‐Voglauer · 2014 · New Biotechnology
- Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 OncoproteinNicholas J. Veomett, Tao Dao, Hong Liu, Jingyi Xiang, Dmitry Pankov, Leonid Dubrovsky, Joseph A. Whitten, Sun‐Mi Park, Tatyana Korontsvit, Victoria Zakhaleva et al. · 2014 · Clinical Cancer Research
- A Novel, Fully Human Anti–fucosyl-GM1 Antibody Demonstrates Potent In Vitro and In Vivo Antitumor Activity in Preclinical Models of Small Cell Lung CancerPaul D. Ponath, Daniel Lopes De Menezes, Chin Pan, Bing Y. Chen, Miho Oyasu, Debbie C. Strachan, Heidi N. LeBlanc, Huadong Sun, Xi-Tao Wang, Vangipuram S. Rangan et al. · 2018 · Clinical Cancer Research
- Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCCRoland Repp, Christian Kellner, Anja Muskulus, Matthias Staudinger, Sahar Mohseni Nodehi, Pia Glorius, Dalia Akramienė, Michael Dechant, Georg H. Fey, Patrick H.C. van Berkel et al. · 2011 · Journal of Immunological Methods
- γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity AssayUrsula J. E. Seidel, Fabian Vogt, Ludger Große‐Hovest, Gundram Jung, Rupert Handgretinger, Peter Lang · 2014 · Frontiers in Immunology
- Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesNgoc Phuong Lan Le, Thomas A. Bowden, Weston B. Struwe, Max Crispin · 2016 · Biochimica et Biophysica Acta (BBA) - General Subjects
- Model-based analysis of N-glycosylation in Chinese hamster ovary cellsFrederick J. Krambeck, Sandra V. Bennun, Mikael Rørdam Andersen, Michael J. Betenbaugh · 2017 · PLoS ONE
- A comparison of three techniques for quantitative carbohydrate analysis used in characterization of therapeutic antibodiesJoseph Siemiatkoski, Yelena V. Lyubarskaya, Damian J. Houde, Samnang Tep, Rohin Mhatre · 2005 · Carbohydrate Research
- Fc Glycans Terminated withN-Acetylglucosamine Residues Increase Antibody Resistance to PapainT. Shantha Raju, Bernard J. Scallon · 2007 · Biotechnology Progress
- Dual-regulated expression technology: a new era in the adjustment of heterologous gene expression in mammalian cellsSamuel Moser, Markus Rimann, Cornelia Fux, Stefan Schlatter, James E. Bailey, Martin Fussenegger · 2001 · The Journal of Gene Medicine
- Direct and immune mediated antibody targeting of ERBB receptors in a colorectal cancer cell-line panelShazad Q. Ashraf, Angela M. Nicholls, Jennifer L. Wilding, Triantafyllia G. Ntouroupi, Neil Mortensen, Walter Fred Bodmer · 2012 · Proceedings of the National Academy of Sciences
- Biological consequences of overexpressing or eliminating N-acetylglucosaminyltransferase-TIII in the mousePamela Stanley · 2002 · Biochimica et Biophysica Acta (BBA) - General Subjects
- The dynamic behavior of storage organelles in developing cereal seeds and its impact on the production of recombinant proteinsElsa Arcalís, Verena Ibl, Jenny Peters, Stanislav Melnik, Eva Stöger · 2014 · Frontiers in Plant Science
- A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignanciesPina M. Cardarelli, Chetana Rao‐Naik, Sharline Chen, Haichun Huang, Amie Pham, Maria-Cristina Moldovan-Loomis, Chin Pan, Ben Preston, David Passmore, Jie Liu et al. · 2009 · Cancer Immunology Immunotherapy
- Controlling the time evolution of mAb N‐linked glycosylation, Part I: Microbioreactor experimentsThomas K. Villiger, Anaïs Roulet, Arnaud Périlleux, Matthieu Stettler, Hervé Broly, Massimo Morbidelli, Miroslav Šoóš · 2016 · Biotechnology Progress
- Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal ImmunoglobulinsAdrien Bosseboeuf, Sophie Allain‐Maillet, Nicolas Mennesson, Anne Tallet, Cédric Rossi, Laurent Garderet, Denis Caillot, Philippe Moreau, Éric Piver, François Girodon et al. · 2017 · Frontiers in Immunology
- Distribution of abnormal IgG glycosylation patterns from rheumatoid arthritis and osteoarthritis patients by MALDI-TOF-MS nDehui Sun, Fanlei Hu, Huanyu Gao, Zhijing Song, Wenchun Xie, Ping Wang, Lianjie Shi, Ke Wang, Yan Li, Chuncui Huang et al. · 2019 · The Analyst
- Production of Antibodies in Plants: Approaches and PerspectivesKi Sung Ko, Robert Brodzik, Zenon Steplewski · 2009 · Current topics in microbiology and immunology
- Glycosylation Variations with Expression Systems and Their Impact on Biological Activity of Therapeutic ImmunoglobulinsT. Shantha Raju · 2003
- Genetic engineering approaches to improve posttranslational modification of biopharmaceuticals in different production platformsAmann, Thomas, Schmieder, Valerie, Faustrup Kildegaard, Helene, Borth, Nicole, Andersen, Mikael Rørdam · 2019 · Biotechnology and Bioengineering
- IgG Fc N-glycosylation: Alterations in neurologic diseases and potential therapeutic target?Yannick Kronimus, Richard C. Dodel, Sebastian Peter Galuska, Sascha Neumann · 2018 · Journal of Autoimmunity
- Monoclonal and recombinant antibodies, 30 years after …Emmanuelle Laffly, Régis Sodoyer · 2006 · Human Antibodies
- Glycans in Sera of Amyotrophic Lateral Sclerosis Patients and Their Role in Killing Neuronal CellsMeital Edri‐Brami, Benyamin Rosental, Dana Hayoun, Michael Welt, Hila Rosen, Itzhak Wirguin, Beatrice Nefussy, Vivian E. Drory, Angel Porgador, Rachel G. Lichtenstein · 2012 · PLoS ONE
- Rapid production of recombinant human IgG With improved ADCC effector function in a transient expression systemPatrick H.C. van Berkel, Jolanda Gerritsen, Edwin van Voskuilen, Gerrard J. Perdok, Tom Vink, Jan G. J. van de Winkel, Paul W.H.I. Parren · 2009 · Biotechnology and Bioengineering
- High‐resolution definition of humoral immune response correlates of effective immunity against HIVGalit Alter, Karen G. Dowell, Eric P. Brown, Todd J. Suscovich, Anastassia Mikhailova, Alison E. Mahan, Bruce D. Walker, Falk Nimmerjahn, Chris Bailey‐Kellogg, Margaret E. Ackerman · 2018 · Molecular Systems Biology
- Supplementing glycosylation: A review of applying nucleotide-sugar precursors to growth medium to affect therapeutic recombinant protein glycoform distributionsBlondeel, Eric J.M., Aucoin, Marc G. · 2018 · Biotechnology Advances
- Engineered Protease-resistant Antibodies with Selectable Cell-killing FunctionsMichelle Kinder, Allison R. Greenplate, Katharine D. Grugan, Keri L. Soring, Katharine Heeringa, Stephen G. McCarthy, Gregory Bannish, Meredith Perpetua, Frank Lynch, Robert E. Jordan et al. · 2013 · Journal of Biological Chemistry
- Fc‐engineered EGF‐R antibodies mediate improved antibody‐dependent cellular cytotoxicity (ADCC) against KRAS ‐mutated tumor cellsMartin Schlaeth, Sven Berger, Stefanie Derer, Katja Klausz, Stefan Lohse, Michael Dechant, Greg A. Lazar, Tanja Schneider‐Merck, Matthias Peipp, Thomas Valerius · 2010 · Cancer Science
- Transcriptional Profiling of Gene Expression Changes in a PACE-Transfected CHO DUKX Cell Line Secreting High Levels of rhBMP-2Padraig Doolan, Mark W. Melville, Patrick Gammell, Martin S. Sinacore, Paula Meleady, Kevin John McCarthy, Linda Francullo, Mark W. Leonard, Timothy S. Charlebois, MARTIN M. CLYNES · 2008 · Molecular Biotechnology
- Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cellsFabrizio Marcucci, Matteo Bellone, Cristiano Rumio, Angelo Corti · 2013 · mAbs
- Galactosyltransferase 4 is a major control point for glycan branching in N-linked glycosylationAndrew G. McDonald, Jerrard M. Hayes, Tania Bezak, Sonia Agnieszka Gluchowska, Eoin F. J. Cosgrave, Weston B. Struwe, Corné J.M. Stroop, Han J Kok, Teun van de Laar, Pauline Mary Rudd et al. · 2014 · Journal of Cell Science
- Engineering of Yeast Glycoprotein ExpressionCharlot De Wachter, Linde Van Landuyt, Nico Callewaert · 2018 · Advances in biochemical engineering, biotechnology
- High accuracy differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma by immunoglobulin G glycosylationHsi‐Chang Shih, Ming‐Chu Chang, Chein‐Hung Chen, I‐Lin Tsai, San‐Yuan Wang, Ya-Po Kuo, Chung‐Hsuan Chen, Yu‐Ting Chang · 2019 · Clinical Proteomics
- Synthetic glycobiology: exploits in the Golgi compartmentJennifer L. Czlapinski, Carolyn Ruth Bertozzi · 2006 · Current Opinion in Chemical Biology
- Functional cross‐kingdom conservation of mammalian and moss (Physcomitrella patens) transcription, translation and secretion machineriesMarc Gitzinger, Juliana Parsons, Ralf Reski A, Martin Fussenegger · 2008 · Plant Biotechnology Journal
- The role of antibody glycosylation in autoimmune and alloimmune kidney diseasesAnaïs Beyze, Christian Larroque, Moglie Le Quintrec · 2024 · Nature Reviews Nephrology
- Identification of Dominant Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Antigen of Pandemic H1N1 Influenza VirusVikram Srivastava, Zheng Yang, Ivan Fan‐Ngai Hung, Jianqing Xu, Bo‐Jian Zheng, Yijun Zhang · 2013 · Journal of Virology
- Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseasesDan Zhang, Bingchao Chen, Yanmin Wang, Peng Xia, Chengyan He, Yujie Liu, Ruiqing Zhang, Mo Zhang, Zhili Li · 2016 · Scientific Reports
- An Update of pTRIDENT Multicistronic Expression Vectors: pTRIDENTs Containing Novel Streptogramin-Responsive PromotersSamuel Moser, Stefan Schlatter, Cornelia Fux, Markus Rimann, James E. Bailey, Martin Fussenegger · 2000 · Biotechnology Progress
- Modulating antibody effector functions by Fc glycoengineeringMikel García-Alija, Berre Van Moer, Diego E. Sastre, Tala Azzam, Jonathan J. Du, Beatriz Trastoy, Nico Callewaert, Eric J. Sundberg, Marcelo E. Guerin · 2023 · Biotechnology Advances
- Preparation of recombinant vaccinesÉric Soler, Louis‐Marie Houdebine · 2007 · Biotechnology annual review
- A high‐throughput microchip‐based glycan screening assay for antibody cell culture samplesJeremy Primack, Gregory C. Flynn, Hai Pan · 2011 · Electrophoresis
- Improved production of monoclonal antibodies through oxygen-limited cultivation of glycoengineered yeastMarina Berdichevsky, Marc d′Anjou, Muralidhar R. Mallem, Seemab S. Shaikh, Thomas I. Potgieter · 2011 · Journal of Biotechnology
- A combinatorial genetic library approach to target heterologous glycosylation enzymes to the endoplasmic reticulum or the Golgi apparatus of Pichia pastorisJuergen H. Nett, Terrance A. Stadheim, Huijuan Li, Piotr Bobrowicz, Stephen R. Hamilton, Robert C. Davidson, Byung‐Kwon Choi, Teresa Mitchell, Beata Bobrowicz, Alissa M. Rittenhour et al. · 2010 · Yeast
- A variant human IgG1-Fc mediates improved ADCCRoss A. Stewart, George Thom, Michaela Levens, Gülin Güler-Gane, Robert Holgate, Pauline Mary Rudd, Carl I. Webster, Lutz Jermutus, John Lund · 2011 · Protein Engineering Design and Selection
- High-throughput profiling of nucleotides and nucleotide sugars to evaluate their impact on antibody N-glycosylationThomas K. Villiger, Robert Steinhoff, Marija Ivarsson, Thomas Solacroup, Matthieu Stettler, Hervé Broly, Jasmin Krismer, Martin Pabst, Renato Zenobi, Massimo Morbidelli et al. · 2016 · Journal of Biotechnology
- IgG N-glycansSi Liu, Xin Liu · 2021 · Advances in clinical chemistry
- Glycosylation of Natural and Recombinant Antibody MoleculesRoy Jefferis · 2005 · Advances in experimental medicine and biology
- Engineered anti‐CD20 antibodies with enhanced complement‐activating capacity mediate potent anti‐lymphoma activityAkito Natsume, Yukiko Shimizu‐Yokoyama, Mitsuo Satoh, Kenya Shitara, Rinpei Niwa · 2009 · Cancer Science
- Change in I g G 1 F c N ‐linked glycosylation in human lung cancer: Age‐ and sex‐related diagnostic potentialGuoqiang Chen, Yanmin Wang, Xuzhen Qin, Hexiang Li, Yumei Guo, Yanying Wang, Hui Liu, Xiaodong Wang, Gaoguang Song, Fang Li et al. · 2013 · Electrophoresis
- Glycoforms of Immunoglobulin G Based Biopharmaceuticals Are Differentially Cleaved by Trypsin Due to the Glycoform Influence on Higher-Order StructureDavid Falck, Bas C. Jansen, Rosina Plomp, Dietmar Reusch, Markus Haberger, Manfred Wuhrer · 2015 · Journal of Proteome Research
- Glycoengineering design options for IgG1 in CHO cells using precise gene editingMorten Alder Schulz, Weihua Tian, Yang Mao, Julie Van Coillie, Lingbo Sun, Joachim Steen Larsen, Yen‐Hsi Chen, Claus Kristensen, Sergey Y. Vakhrushev, Henrik Clausen et al. · 2018 · Glycobiology
- Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary namesIan C. Wilkinson, G Hale · 2022 · mAbs
- Mammalian Cell Culture for Biopharmaceutical ProductionJinyou Zhang · 2014 · ASM Press eBooks
- Glycoengineering Chinese hamster ovary cells: a short historyDonini, Roberto, Haslam, Stuart M., Kontoravdi, Cleo · 2021 · Biochemical Society Transactions
- Monoclonal anti-D antibodies to prevent alloimmunization: lessons from clinical trialsRoland Béliard · 2006 · Transfusion Clinique et Biologique
- Glycoengineering Approach to Half-Life Extension of Recombinant BiotherapeuticsChen Chen, Antony Constantinou, Kerry Ann Chester, Bijal Vyas, Kévin Canis, Stuart M. Haslam, Anne Dell, Agamemnon A. Epenetos, Mahendra P. Deonarain · 2012 · Bioconjugate Chemistry
- Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th CellsMichael Storcksdieck genannt Bonsmann, Thomas Niezold, Vladimir Temchura, Franco Pissani, Katrin Ehrhardt, Eric P. Brown, Nana Yaw Osei‐Owusu, Drew Hannaman, Hartmut Hengel, Margaret E. Ackerman et al. · 2015 · The Journal of Immunology
- An Inflammatory Story: Antibodies in Tuberculosis ComorbiditiesMilla R. McLean, Lenette L. Lu, Stephen John Kent, Amy W. Chung · 2019 · Frontiers in Immunology
- Versatile macrolide‐responsive mammalian expression vectors for multiregulated multigene metabolic engineeringWilfried Weber, René R. Marty, Bettina Keller, Markus Rimann, Beat P. Kramer, Martin Fussenegger · 2002 · Biotechnology and Bioengineering
- Global insights into the Chinese hamster and CHO cell transcriptomesNandita Vishwanathan, Andrew Yongky, Kathryn C. Johnson, Hsu‐Yuan Fu, Nitya M. Jacob, Huong Le, Faraaz N.K. Yusufi, Dong‐Yup Lee, Wei‐Shou Hu · 2014 · Biotechnology and Bioengineering
- Recent advances in the analysis of carbohydrates for biomedical useKeita Yamada, Kazuaki Kakehi · 2011 · Journal of Pharmaceutical and Biomedical Analysis
- Enhanced sialylation of a human chimeric IgG1 variant produced in human and rodent cell linesYusuke Mimura, Ronan M. Kelly, Louise Unwin, Simone Albrecht, Roy Jefferis, Margaret D Goodall, Yoichi Mizukami, Yuka Mimura‐Kimura, Tsuneo Matsumoto, Hiroshi Ueoka et al. · 2015 · Journal of Immunological Methods
- Site-specific immobilization of endoglycosidases for streamlined chemoenzymatic glycan remodeling of antibodiesTiezheng Li, Chao Li, David N. Quan, William E. Bentley, Lai‐Xi Wang · 2018 · Carbohydrate Research
- Enhanced Fc-Dependent Cellular Cytotoxicity of Fc Fusion Proteins Derived from TNF Receptor II and LFA-3 by Fucose Removal from Asn-Linked OligosaccharidesEmi Shoji-Hosaka, Yukari Kobayashi, Masako Wakitani, Kazuhisa Uchida, Rinpei Niwa, Kazuyasu Nakamura, Kenya Shitara · 2006 · The Journal of Biochemistry
- In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in Nicotiana benthamiana PlantsVally Kommineni, Matthew Markert, Zhongjie Ren, Sreenath Palle, Berenice Carrillo, Jasmine Deng, Armando Tejeda, Somen Nandi, Karen A. McDonald, Sylvain Marcel et al. · 2019 · International Journal of Molecular Sciences
- A Review of Antibody Therapeutics and Antibody-Related Technologies for OncologyBernard J. Scallon, Linda A. Snyder, G. Mark Anderson, Qiming Chen, Yan Li, Louis M. Weiner, Marian T. Nakada · 2006 · Journal of Immunotherapy
- Quantitative in vivo comparisons of the Fcγ receptor-dependent agonist activities of different fucosylation variants of an immunoglobulin G antibodyBernard J. Scallon, Stephen G. McCarthy, Jennifer Radewonuk, Ann Cai, Michael F. Naso, T. Shantha Raju, Renold J. Capocasale · 2007 · International Immunopharmacology
- Diversity in host clone performance within a C hinese hamster ovary cell linePeter M. O’Callaghan, Maud E. Berthelot, Robert J. Young, James W.A. Graham, Andrew J. Racher, Dulce Aldana · 2015 · Biotechnology Progress
- Centralized Modularity of N-Linked Glycosylation Pathways in Mammalian CellsPan‐Jun Kim, Dong‐Yup Lee, Hawoong Jeong · 2009 · PLoS ONE
- Intravascular survival of red cells coated with a mutated human anti-D antibody engineered to lack destructive activityKathryn L. Armour, David R. Parry-Jones, N. Beharry, James R. Ballinger, Rosey Mushens, R. Keith Williams, Cynthia Beatty, Simon J. Stanworth, Paul Lloyd-Evans, Marion L. Scott et al. · 2005 · Blood
- Biopharmaceutical Proteins: Opportunities and ChallengesJohn R. Birch, Emmanuel Onakunle Onabanjo · 2005 · Humana Press eBooks
- Genentech's glyco-engineered antibody to succeed RituxanMark Ratner · 2014 · Nature Biotechnology
- EB66 cell line, a duck embryonic stem cell-derived substrate for the industrial production of therapeutic monoclonal antibodies with enhanced ADCC activityStéphane Olivier, Marine Jacoby, Cédric Brillon, Sylvana Bouletreau, Thomas Mollet, Olivier Nerrière, Audrey Angel, Sévérine Danet, Boussad Souttou, Fabienne Guéhenneux et al. · 2010 · mAbs
- Partial filling affinity capillary electrophoresis using large-volume sample stacking with an electroosmotic flow pump for sensitive profiling of glycoprotein-derived oligosaccharidesEriko Fukushima, Yuki Yagi, Sachio Yamamoto, Yumi Nakatani, Kazuaki Kakehi, Takao Hayakawa, Shigeo Suzuki · 2012 · Journal of Chromatography A
- XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancerJuergen M. Schanzer, Katharina Wartha, Ekkehard Moessner, Ralf J. Hosse, Samuel Moser, Rebecca Croasdale, Halina Trochanowska, Cuiying Shao, Peng Wang, Lei Shi et al. · 2016 · mAbs
- Engineering novel Lec1 glycosylation mutants in CHO–DUKX cells: Molecular insights and effector modulation of N‐acetylglucosaminyltransferase IXiaotian Zhong, Cecilia Cooley, Nilufer P. Seth, Zong Sean Juo, Ella Presman, Nicole Resendes, Ravi A. Kumar, Martin Allen, Lidia Mosyak, Mark Stahl et al. · 2012 · Biotechnology and Bioengineering
- Orthogonal Technologies for NISTmAb N-Glycan Structure Elucidation and QuantitationJustin M. Prien, Henning Stöckmann, Simone Albrecht, Silvia Millán‐Martín, Matthew Varatta, Marsha Furtado, Stephen Hosselet, Meiyao Wang, Trina Formolo, Pauline Mary Rudd et al. · 2015 · ACS symposium series
- Glycomodification and characterization of anti-colorectal cancer immunotherapeutic monoclonal antibodies in transgenic tobaccoYangkang So, Kyung-Jin Lee, Deuk-Su Kim, Jeong Hwan Lee, Doo‐Byoung Oh, Kyung‐A Hwang, Kinarm Ko, Young‐Kug Choo, Ko Kisung · 2012 · Plant Cell Tissue and Organ Culture (PCTOC)
- Short‐hairpin‐RNA‐mediated silencing of fucosyltransferase 8 in Chinese‐hamster ovary cells for the production of antibodies with enhanced antibody immune effector functionVincent Beuger, Klaus‐Peter Künkele, Hans Koll, Achim Gärtner, Monika Bähner, Helmut J. BURTSCHER, Christian Klein · 2008 · Biotechnology and Applied Biochemistry
- Towards the development of a surface plasmon resonance assay to evaluate the glycosylation pattern of monoclonal antibodies using the extracellular domains of CD16a and CD64July Dorion-Thibaudeau, Céline Raymond, Erika Lattová, Hélène Perreault, Yves Durocher, Grégory De Crescenzo · 2014 · Journal of Immunological Methods
- The Neutralization Properties of a HIV-Specific Antibody Are Markedly Altered by Glycosylation Events Outside the Antigen-Binding DomainLuis R Miranda, Mark Duval, Heather Doherty, Michael S. Seaman, Marshall R. Posner, Lisa A. Cavacini · 2007 · The Journal of Immunology
- State‐of‐the‐art technologies for rapid and high‐throughput sample preparation and analysis of N‐glycans from antibodiesUdayanath Aich, Jude C. Lakbub, Aston Liu · 2016 · Electrophoresis
- Glycobiology of AgingFabio Dall’Olio · 2018 · Sub-cellular biochemistry/Subcellular biochemistry
- Antibody Expression and ProductionMohamed Al‐Rubeai · 2011 · Cell engineering
- Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challengesJean‐Luc Teillaud · 2005 · Expert Opinion on Biological Therapy
- Modulation of translation‐initiation in CHO‐K1 cells by rapamycin‐induced heterodimerization of engineered eIF4G fusion proteinsStefan Schlatter, Claudia Senn, Martin Fussenegger · 2003 · Biotechnology and Bioengineering
- Modern Antibody Technology: The Impact on Drug DevelopmentSimon E. Moroney, Andreas Plückthun · 2005 · Wiley eBooks
- The Association Between Low Back Pain and Composition of IgG GlycomeMaxim B. Freidin, Toma Keser, Ivan Gudelj, Jerko Štambuk, Dunja Vučenović, Massimo Allegri, Tamara Štambuk, Mirna Šimurina, Stella M. Fabiane, Gordan Lauc et al. · 2016 · Scientific Reports
- Impact of IgG Fc‐Oligosaccharides on Recombinant Monoclonal Antibody Structure, Stability, Safety, and EfficacyHongcheng Liu, Christine Nowak, Bruce A. Andrien, Mei Shao, Gomathinayagam Ponniah, Alyssa Neill · 2017 · Biotechnology Progress
- Cell culture media supplementation of uncommonly used sugars sucrose and tagatose for the targeted shifting of protein glycosylation profiles of recombinant protein therapeuticsPatrick Hossler, Sean McDermott, Christopher Racicot, Christopher Chumsae, Haly Raharimampionona, Yu Zhou, David Ouellette, Joseph G. Matuck, Ivan Correia, John Fann et al. · 2014 · Biotechnology Progress
- Glycoprotein biomarkers and analysis in chronic obstructive pulmonary disease and lung cancer with special focus on serum immunoglobulin GAndras Komaromy, Balazs Reider, Gábor Járvás, András Guttman · 2020 · Clinica Chimica Acta
- OUP accepted manuscriptTea Pribić, Inês Alves, Dario Bugada, Julio Pascual, Frano Vučković, Andrea Skelin, Joana Gaifem, Judit Villar-García, Manuel M Vicente, Ângela Fernandes et al. · 2020 · Glycobiology